Literature DB >> 12163363

Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer.

Dae-Sung Yoon1, Robert P Wersto, Weibo Zhou, Francis J Chrest, Elizabeth S Garrett, Teag Kyu Kwon, Edward Gabrielson.   

Abstract

Cytogenetic analyses have revealed that many aneuploid breast cancers have cell-to-cell variations of chromosome copy numbers, suggesting that these neoplasms have instability of chromosome numbers. To directly test for possible chromosomal instability in this disease, we used fluorescent in situ hybridization to monitor copy numbers of multiple chromosomes in cultures of replicating breast cancer-derived cell lines and nonmalignant breast epithelial cells. While most (7 of 9) breast cancer cell lines tested are highly unstable with regard to chromosome copy numbers, others (2 of 9 cell lines) have a moderate level of instability that is higher than the "background" level of normal mammary epithelial cells and MCF-10A cells, but significantly less than that seen in the highly unstable breast cancer cell lines. To evaluate the potential role of a defective mitotic spindle checkpoint as a cause of this chromosomal instability, we used flow cytometry to monitor the response of cells to nocodazole-induced mitotic spindle damage. All cell lines with high levels of chromosomal instability have defective mitotic spindle checkpoints, whereas the cell lines with moderate levels of chromosomal instability (and the stable normal mammary cells and MCF10A cells) arrest in G(2) when challenged with nocodazole. Notably, the extent of mitotic spindle checkpoint deficiency and chromosome numerical instability in these cells is unrelated to the presence or absence of p53 mutations. Our results provide direct evidence for chromosomal instability in breast cancer and show that this instability occurs at variable levels among cells from different cancers, perhaps reflecting different functional classes of chromosomal instability. High levels of chromosomal instability are likely related to defective mitotic checkpoints but not to p53 mutations.

Entities:  

Mesh:

Year:  2002        PMID: 12163363      PMCID: PMC1850727          DOI: 10.1016/S0002-9440(10)64194-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Cytogenetic features of twenty-six primary breast cancers.

Authors:  P J Hainsworth; K L Raphael; R G Stillwell; R C Bennett; O M Garson
Journal:  Cancer Genet Cytogenet       Date:  1991-06

2.  An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry.

Authors:  B Schutte; M M Reynders; C L van Assche; P S Hupperets; F T Bosman; G H Blijham
Journal:  Cytometry       Date:  1987-07

Review 3.  A mutator phenotype in cancer.

Authors:  L A Loeb
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

4.  Chromosomal instability detected by fluorescence in situ hybridization in Japanese breast cancer patients.

Authors:  S Takami; C Kawasome; M Kinoshita; H Koyama; S Noguchi
Journal:  Clin Chim Acta       Date:  2001-06       Impact factor: 3.786

5.  p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.

Authors:  D M Shin; N Charuruks; S M Lippman; J J Lee; J Y Ro; W K Hong; W N Hittelman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-06       Impact factor: 4.254

6.  Growth of normal human mammary cells in culture.

Authors:  M Stampfer; R C Hallowes; A J Hackett
Journal:  In Vitro       Date:  1980-05

7.  Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells.

Authors:  M J Percy; K A Myrie; C K Neeley; J N Azim; S P Ethier; E M Petty
Journal:  Genes Chromosomes Cancer       Date:  2000-12       Impact factor: 5.006

8.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

9.  Chromosome instability contributes to loss of heterozygosity in mice lacking p53.

Authors:  C Shao; L Deng; O Henegariu; L Liang; P J Stambrook; J A Tischfield
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

10.  Mutations in p53 as potential molecular markers for human breast cancer.

Authors:  I B Runnebaum; M Nagarajan; M Bowman; D Soto; S Sukumar
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

View more
  38 in total

1.  A cell-based assay for screening spindle checkpoint inhibitors.

Authors:  Zhen Hua Wu; Long Yu Hu; Da Qian Xu; Xiaotong Li
Journal:  Assay Drug Dev Technol       Date:  2012-02-21       Impact factor: 1.738

Review 2.  Mechanisms of chromosomal instability.

Authors:  Sarah L Thompson; Samuel F Bakhoum; Duane A Compton
Journal:  Curr Biol       Date:  2010-03-23       Impact factor: 10.834

3.  SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.

Authors:  Nathalie Cohet; Kathleen M Stewart; Rajini Mudhasani; Ananthi J Asirvatham; Chandrashekara Mallappa; Karen M Imbalzano; Valerie M Weaver; Anthony N Imbalzano; Jeffrey A Nickerson
Journal:  J Cell Physiol       Date:  2010-06       Impact factor: 6.384

4.  Spindle checkpoint and apoptotic response in alpha-particle transformed human bronchial epithelial cells.

Authors:  J-L Sui; J An; J-F Sun; Y Chen; D-C Wu; P-K Zhou
Journal:  Radiat Environ Biophys       Date:  2004-12-18       Impact factor: 1.925

5.  Image analysis of the AgNOR response in ras-transformed human breast epithelial cells.

Authors:  Maria Luiza S Mello; Benedicto C Vidal; Jose Russo; Wolfgang Planding; Ulrich Schenck
Journal:  Acta Histochem       Date:  2007-12-26       Impact factor: 2.479

6.  Three-Dimensional Cellular Raman Analysis: Evidence of Highly Ordered Lipids Within Cell Nuclei.

Authors:  Bhagavathi Ramamurthy; Stanley Cohen; Mark Canales; Frederick D Coffman
Journal:  J Histochem Cytochem       Date:  2018-08-23       Impact factor: 2.479

7.  BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD).

Authors:  Y Niikura; H Ogi; K Kikuchi; K Kitagawa
Journal:  Cell Death Differ       Date:  2010-01-08       Impact factor: 15.828

8.  Tamoxifen-stimulated growth of breast cancer due to p21 loss.

Authors:  Abde M Abukhdeir; Michele I Vitolo; Pedram Argani; Angelo M De Marzo; Bedri Karakas; Hiroyuki Konishi; John P Gustin; Josh Lauring; Joseph P Garay; Courtney Pendleton; Yuko Konishi; Brian G Blair; Keith Brenner; Elizabeth Garrett-Mayer; Hetty Carraway; Kurtis E Bachman; Ben Ho Park
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-27       Impact factor: 11.205

9.  Mitotic arrest deficiency 2 induces carcinogenesis in mucinous ovarian tumors.

Authors:  Yusuke Nakano; Toshiyuki Sumi; Masanari Morishita; Takeshi Fukuda; Hiroyuki Nobeyama; Hiroyuki Yoshida; Yoshinari Matsumoto; Tomoyo Yasui; Osamu Ishiko
Journal:  Oncol Lett       Date:  2011-11-15       Impact factor: 2.967

10.  Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro.

Authors:  M Prencipe; P Fitzpatrick; S Gorman; M Tosetto; M Mosetto; R Klinger; F Furlong; M Harrison; D O'Connor; I B Roninson; J O'Sullivan; A McCann
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.